News
Media
Conferences
Events
Partners
Publications
Resources
Biomarker Consortium
Subscribe

Colton Jones, MD

Colton Jones, MD, is a medical oncologist at UT Health San Antonio

Articles by Colton Jones, MD

Christopher Lieu, MD

Dr Jones on the Protective Benefit and Tolerability of GLP-1 Agonists vs Aspirin for CRC Prevention

ByColton Jones, MD

May 14th 2026

Colton Jones, MD, shares data from a retrospective analysis of GLP-1 receptor agonists vs aspirin for the primary prevention of colorectal cancer.

Christopher Lieu, MD

Dr Jones on the Rationale for Comparing CRC Risk Reduction With GLP-1 Agonists vs Aspirin

ByColton Jones, MD

April 30th 2026

Colton Jones, MD, discusses real-world data comparing GLP-1 receptor agonists and aspirin for the primary prevention of colorectal cancer.

Latest Updated Articles

Trending on OncLive

Pumitamig Plus Chemo Demonstrates Encouraging Efficacy in Frontline NSCLC

Experts Weigh In on Some of the Most Impactful Data in Melanoma From ASCO 2026

Oral Administration Afforded by CDK2 Inhibitors May Ease the Price of Admission in Platinum-Resistant Ovarian Cancer

A global, randomized, double-blinded, Phase 3 trial of vorasidenib vs placebo in patients with grade 2 glioma with an IDH1/2 mutation (INDIGO): updated efficacy and safety

Lutetium Lu 177 Vipivotide Tetraxetan Provides rPFS Benefit in mHSPC Regardless of Disease Volume or De Novo/Recurrent Status